
In October,
‘01, the National Eye Institute publicized the results of the Age Related Eye
Disease Study (“AREDS”). Among other
things, the study investigated vision loss from age related maculopathy (“ARM,”
also called ‘age-related macular degeneration’ or AMD). Several patient groups were followed for a
7-year period, some taking vitamin supplements and some not. In the study, patients were given either
antioxidant vitamins alone, zinc alone, zinc plus vitamins, or placebo. Loss of vision and/or advancement of ARM was
tracked along with other factors. Here
are the results.
In the group using antioxidants alone, over a 7-year
period, vision loss was reduced by 10% compared to a ‘control’ group taking
placebo without antioxidants.
Development of advanced ARM was reduced by 17% compared to the placebo
group. Using zinc alone, over the same
period, vision loss was reduced by 11% compared to the placebo group. Development of ARM was reduced by 21%. Using a combination of antioxidants and
zinc, vision loss was reduced by 19% compared to the placebo group. Development of ARM was reduced by 25%. Interestingly, the AREDS study found that
dietary supplements had NO apparent beneficial effect on the appearance or
progression of cataract.
This
study provides the first scientific data that vitamin supplements can reduce
vision loss and affect the course of ARM. However, some perspective is needed: At 7
years, 30% of the supplemented group had progression of ARM, vs. 40% of the
placebo group. These numbers are statistically significant, but do not
represent a cure for this very troublesome and common disease. Also, a significant benefit was fount only
for those with pre-existing ARM. In
patients with extremely slight ARM not affecting vision, no beneficial effect was
found. Patients in this latter group
may take longer to develop vision loss related to ARM than the 7 years over
which the study was conducted.
Of significance to me is to the specific
formula of antioxidant vitamins and zinc used in this study. Bausch & Lomb supplied a custom formula,
not at all similar to the commercial supplement preparations now widely
available, which include “OcuVite” and “I-Caps” among others. In addition, all patients in the study (including
the placebo group) were allowed to take Centrum to meet their regular, daily
multivitamin needs. Interestingly, 70%
of the patients in the AREDS study did take Centrum in addition to the
supplements studied.
The following table shows the specific
components incorporated into common commercial vitamin supplements, and that
for the AREDS study. Copper
supplementation was included in the formulation to prevent possible development
of copper deficiency, which is known to be associated with increased zinc
intake in adults.
Preparation Vitamin A Vitamin
C Vitamin E Zinc
Copper
(IU) (mg) (mg)
(mg) (mg)
OcuVite Extra Lutein
1,000 300
100 40 2.0
I-Caps Lutein 6,600
400 150
60 4.0
AREDS Study Formula
7,610 113
100 17.5 0.4
Centrum Multivitamins 5,000 60 30 15 2.0 *
* Centrum also contains: Vitamin D 400U, Vitamin K 25mcg, Thiamine 1.5mg,
Riboflavin 1.7mg, Niacin 20mg, Vitamin B6 2mg, Folic acid 400mcg, Vitamin B12
6mcg, Biotin 30mcg, Pantothenic acid 10mg, Calcium 162mg, Iron 18mg, Phosporous
109mg, Iodine 150mcg, Magnesium 100mg, Selenium 20ug, Manganese 2mg, Chromium
120mcg, Chloride 72mg, Potassium 80mg, Molybdenum 75mcg, Boron 150ug, Nickel
5ug, Silicone 2mg, Tin 10ug, Vanadium 10ug, Lutein 250ug
Conclusions
& Recommendations: For the first time, the National Eye Institute
is advising that everyone at risk for ARM consider taking appropriate vitamin supplements. This
includes people of Caucasian descent over 50 years of age, and anyone with a
family history of ARM. It is now clear
that antioxidant vitamins and certain mineral supplements can definitely affect
the course of certain age-related eye diseases that contribute to significant
vision impairment in the senior population.
If you are concerned about your vision and/or your risk for ARM, call our office at (310) 828-2020 and set
up an appointment with Dr. Wallace.
Where Can I Obtain the Recommended Formulation Used in the
Study? We now have scientific evidence to guide
recommendations for daily vitamin and mineral supplement doses. The
composition of supplements in the AREDS study was very different than that in
current commercially available “eye vitamin” preparations. Our office can assist you in finding and
obtaining the proper formulations if you wish.
Please refer to the “formulation” note below for specifics.
Are
There Any Side Effects from the Nutrients? The AREDS participants reported
few side effects from the treatments. About 7.5 percent of participants
assigned to the zinc treatments--compared with five percent who did not have
zinc in their assigned treatment--had urinary tract problems that required
hospitalization. Participants in the two groups that took zinc also reported
anemia at a slightly higher rate; however, testing of all patients for this
disorder showed no difference among treatment groups. Yellowing of the skin, a
well-known side effect of large doses of beta-carotene, was reported slightly
more often by participants taking antioxidants. In two large clinical trials
sponsored by the National Cancer Institute, beta-carotene was shown to
significantly increase the risk of lung cancer among smokers.
Formulation: For most
ARM patients, we should try to suggest a daily supplement which duplicates the
one used in the study. This can be accomplished
with the following regimen:
Vitamin
A (Beta Carotene): one 25,000 IU tablet
(15mg) daily
Vitamin
C: one 500mg tablet daily
Vitamin
E: 400 IU daily
Zinc
(as zinc oxide): 80mg daily
Centrum Silver with
Lutein: one daily.
(Lutein supplementation was not studied in the
AREDS, as the study commenced prior to discovery of lutein’s potential benefits
and before availability in dietary supplements became widespread.)